chlordecone has been researched along with tamoxifen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
Chae, K; Davis, VL; Newbold, RR; Shelby, MD; Tully, DB | 1 |
Annab, LA; Archer, TK; Bortner, CD; Collins, JM; Dixon, D; Karimi Kinyamu, H; Shah, RR; Sifre, MI | 1 |
3 other study(ies) available for chlordecone and tamoxifen
Article | Year |
---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays.
Topics: Animals; Binding, Competitive; Biological Assay; Chlordecone; DDT; Dose-Response Relationship, Drug; Endosulfan; Environmental Pollutants; Estrogens; Female; Hazardous Substances; HeLa Cells; Humans; In Vitro Techniques; Methoxychlor; Mice; Phenols; Receptors, Estrogen; Tamoxifen; Transcriptional Activation; Uterus | 1996 |
Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.
Topics: Antigens, Differentiation; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Apigenin; Cell Cycle; Cell Differentiation; Cell Line; Chlordecone; COUP Transcription Factor II; Embryonic Stem Cells; Endocrine Disruptors; Gene Expression Profiling; Gene Expression Regulation, Developmental; Homeodomain Proteins; Humans; Kaempferols; Nanog Homeobox Protein; Octamer Transcription Factor-3; Pluripotent Stem Cells; Proteoglycans; Signal Transduction; Stage-Specific Embryonic Antigens; Tamoxifen; Tretinoin | 2012 |